According to EvoHealth's Sharon Musgrave, who led the report's development, “With the results observed to date in clinical trials of CAR T-cell therapies and more than a thousand ongoing trials investigating CAR T-cell therapy, the time to prepare the clinical workforce and establish nationwide funding is now.”
New report calls for the development and adoption of a national plan for CAR T-cell therapy
May 9, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
OncoSil charts a new growth phase as Chairman outlines progress and opportunities
November 19, 2025 - - Latest News -
CSL unveils US expansion, cementing its position as a global biopharma leader
November 19, 2025 - - Latest News -
Cleo Diagnostics appoints U.S. oncologist as first key opinion leader
November 19, 2025 - - Australian Biotech -
IDT Australia resets strategy as advanced therapies drive new phase of growth
November 19, 2025 - - BioPharma -
Dimerix Phase 3 kidney trial clears seventh safety review
November 19, 2025 - - Australian Biotech -
Prescient secures EU orphan status for PTX-100 for cutaneous T-cell lymphomas
November 19, 2025 - - Australian Biotech -
BCAL advances early cancer detection portfolio as Australian launch looms
November 19, 2025 - - Australian Biotech